IDEX IDEX Biometrics ASA

IDEX Biometrics begins trading on the OTCQB Venture Market in the United States

IDEX Biometrics begins trading on the OTCQB Venture Market in the United States

Oslo, Norway, 11 November 2019: IDEX Biometrics ASA, a leading provider of advanced fingerprint identification and authentication solutions, has been approved to trade on the OTCQB Venture Market exchange under the ticker symbol IDXAF and trading will commence today.

The OTCQB Venture Market offers companies the benefits of being publicly traded in the U.S. with lower cost and complexity than listing on the large U.S. exchanges. To be eligible, international companies must be current in the local market filings and undergo an annual verification and management certification process.

As a verified market with efficient access for U.S. investors, OTCQB helps international companies build shareholder value by enhancing liquidity and achieving fair valuation. B. Riley FBR, Inc., a U.S. based investment bank which has extensive experience in the OTC process, acted as the Company’s sponsor for this process.

Derek D’Antilio, CFO of IDEX Biometrics commented: “The OTCQB market informs investors and potential investors that IDEX meets or exceeds the standards of reporting and transparency. In addition, it was important to us to provide investors in the U.S. easy and efficient access to trade IDEX’s shares. Trading on the OTCQB market serves as a gateway to the U.S. capital markets for IDEX.”

For further information contact:

Stuart Hunt, Head of Investor Relations & Communications

+44 (0)1276 534 632

About IDEX Biometrics

IDEX Biometrics ASA (OSE: IDEX and OTC: IDXAF) is a leading provider of fingerprint identification technologies offering simple, secure and personal authentication for all.  We help people make payments, prove their identity, gain access to information, unlock devices or gain admittance to buildings with the touch of a finger.  We invent, engineer, and commercialize these secure, yet incredibly user-friendly solutions.  Our total addressable market represents a fast growing multi-billion-unit opportunity.

For more information, visit and follow @IDEXBiometrics

About OTC Markets Group Inc.

(OTCQX: OTCM) operates the OTCQX Best Market, the OTCQB Venture Market and the Pink Open Market for 10,000 U.S. and global securities.  Through OTC Link ATS and OTC Link ECN, we connect a diverse network of broker-dealers that provide liquidity and execution services.  We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors. OTC Link ATS and OTC Link ECN are SEC regulated ATSs, operated by OTC Link LLC, member FINRA/SIPC.

To learn more about how we create better informed and more efficient markets, visit  

---

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

EN
11/11/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IDEX Biometrics ASA

 PRESS RELEASE

IDEX Biometrics ASA – EX. SHARE CONSOLIDATION (REVERSE SPLIT) TODAY - ...

IDEX Biometrics ASA – EX. SHARE CONSOLIDATION (REVERSE SPLIT) TODAY - 9 Jan 2024 Issuer name: IDEX Biometrics ASA Ex. date: 9 January 2024 Type of corporate action: Share consolidation (reverse split) Previous ISIN: NO0003070609 New ISIN: NO0013107490 For further information contact:Marianne Bøe, Investor RelationsE-mail: Tel: About this noticeThis notice was published by Erling Svela, Vice president of finance, on 9 January 2024 at 08:00 CET on behalf of IDEX Biometrics ASA. The information shall be disclosed according to Continuing Obligations at Oslo Børs Euronext and is published ...

 PRESS RELEASE

IDEX Biometrics ASA – EX. AKSJESPLEIS I DAG – 9. januar 2024

IDEX Biometrics ASA – EX. AKSJESPLEIS I DAG – 9. januar 2024 Utstedernavn: Idex Biometrics ASA Ex. Dato: 9. januar 2024 Type selskapshandling: Aksjespleis Tidligere ISIN: NO0003070609 Ny ISIN: NO0013107490 For ytterligere informasjon kontact:Marianne Bøe, investorkontaktE-mail: Tel: Om denne meldingenDenne meldingen ble publisert av økonomisjef Erling Svela den 9. januar 2024 kl 08:00 CET på vegne av IDEX Biometrics ASA. Informasjonen skal offentligjøres iht løpende forpliktelser ved Oslo Børs Euronext og utsendes i tråd med paragraf 5‑12 i verdipapirhandelloven.

 PRESS RELEASE

Registration of share consolidation (reverse split) in IDEX Biometrics...

Registration of share consolidation (reverse split) in IDEX Biometrics - 8 Jan 2024 Reference is made to the notice on 21 December 2023 about the five-to-one share consolidation (reverse split) resolved by the extraordinary general meeting on the same day, agenda item 3. The consolidation has been registered. Following the registration, the company's share capital remains NOK 209,551,597.50, but is now divided into 279,402,130 shares, each with a nominal value of NOK 0.75. For the avoidance of doubt, the registration does not affect the dates set forth in the notice of key informatio...

 PRESS RELEASE

Registration of share capital increase in IDEX Biometrics 29 Dec 2023

Registration of share capital increase in IDEX Biometrics 29 Dec 2023 Reference is made to the notice on 22 December 2023 regarding issue of two shares  at NOK 0.15 per shareto an employee of the company as part of the five-to-one share consolidation resolved by the extraordinary general meeting on 21 December 2023, agenda item 3. The consolidation of shares will take place on or about 10 January 2024. Reference is made to the notice of the extraordinary general meeting issued on 30 November 2023 and the notice of resolutions made by the extraordinary general meeting issued on 21 December 2...

 PRESS RELEASE

IDEX Biometrics convertible loan agreement completed 28 Dec 2023

IDEX Biometrics convertible loan agreement completed 28 Dec 2023 Reference is made to the notice by IDEX Biometrics ASA on 26 December 2023 that the convertible loan agreement had been entered into. All closing conditions have now been met and satisfied and closing of the convertible bond transaction has been completed. The initial conversion price, NOK 0.7330 per share, was correctly stated in the notice, but the calculation basis should have been phrased as follows: “The initial conversion price will be NOK 0.7330 per share, which is 125% of the lowest volume weighted average price (VWAP...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch